gms | German Medical Science

German Congress of Orthopaedics and Traumatology (DKOU 2024)

22. - 25.10.2024, Berlin

Identification of risk factors in the development of post-operational wound healing complication in soft tissue sarcoma patients

Meeting Abstract

  • presenting/speaker Luisa Kriens - Universitätsklinikum Essen, Essen, Germany
  • Jendrik Hardes - Universitätsklinikum Essen, Klinik für Tumororthopädie, Essen, Germany
  • Wiebke K. Guder - Universitätsklinikum Essen, Klinik für Tumororthopädie, Essen, Germany
  • Nina Myline Engel - Universitätsklinikum Essen, Klinik für Tumororthopädie und Sarkomchirurgie, Essen, Germany
  • Arne Streitbürger - Universitätsklinikum Essen, Klinik für Tumororthopädie und Sarkomchirurgie, Essen, Germany

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2024). Berlin, 22.-25.10.2024. Düsseldorf: German Medical Science GMS Publishing House; 2024. DocAB27-2248

doi: 10.3205/24dkou094, urn:nbn:de:0183-24dkou0949

Published: October 21, 2024

© 2024 Kriens et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objectives: Wound healing complications (WHC) are a known challenge in soft tissue sarcoma surgery.Aim of this study was to evaluate positive and negative predictive values influencing WHC in order to reduce future numbers of cases and improve patients' recovery.

Methods: The study was performed as a single-institutional, retrospective study at a supranational tumor center over a three-year time-period from April 2019 to June 2021. 588 patients were included, out of these 54,3% were initially treated at our center, 45,7% were later referred after insufficient primary surgery. 41 different factors were observed,including general patient information regarding gender and age, as well as general clinical information regarding diagnostics, number of operations, (neo)adjuvant treatment, wound closure, and follow up.

Results and conclusion: Univariate and Multivariate analysis showed no correlation to neither neoadjuvant nor adjuvant radiotherapy (p = .453, p = .553). Main identified negative predictive values were age (p = .002), gender (p = .048), size (p = .002), localization (p = .010), grading (p = .013), bone tissue involvement (p= <.001), number of revision procedures (p = <.001), and presence of metastasis (p = <.001) or other oncologic diseases (p = .039). Interestingly, neoadjuvant Chemotherapy presented as main positive predictive value, reducing the event of WHC (p = .029) and number of overall revision procedures (p = <.001). Leading into our conclusion to screen patients for identified risk factors and when detected to reevaluate planned surgical procedures in terms of two-stage wound closure and free muscle flap.